Risk of a Decline in the Market Prices of Shares Held
First written in FY2016. 8 of 16 entries say "Mitigated", first in FY2021-Q2. Latest entry: FY2026.
The whole theme swung hardest in 2019: 56 of 138 companies on the "Worse" side.
30 other companies' latest entry also says "Mitigated".
- FY2026MitigatedAnnual report
「For the consolidated fiscal year (from 1 April 2025 to 31 March 2026), there were no applicable matters.」
No impairment loss was recognized on investment securities during the fiscal year, indicating a reduction in the impact of valuation-loss risk in terms of actual results, following the previous fiscal year. - FY2026-H1MitigatedAnnual report
「Loss on valuation of investment securities 16 —」
The loss on valuation of investment securities fell from ¥16 million in the same period of the previous year to zero, reducing the impact of valuation losses caused by declines in the market prices of held shares. - FY2025-H1WorsenedAnnual report
「Loss on valuation of investment securities 1 16」
The loss on valuation of investment securities increased from ¥1 million in the same period of the previous year to ¥16 million, indicating that the risk of declines in the market prices of held shares increased during the current interim consolidated fiscal period. - FY2024-Q3MitigatedAnnual report
「Loss on valuation of investment securities 260 5」
The loss on valuation of investment securities for the cumulative third quarter was ¥5 million, substantially down from ¥260 million in the same period of the previous year. - FY2024-Q2MitigatedAnnual report
「Loss on valuation of investment securities 260 1」
The loss on valuation of investment securities for the cumulative second quarter was ¥1 million, substantially down from ¥260 million in the same period of the previous year. - FY2023WorsenedAnnual report
「During the consolidated fiscal year, the Company recognized an impairment loss of ¥260 million on shares other than shares without market prices among other securities.」
The risk of declines in the market prices of held shares was reflected in the recognition of a ¥260 million impairment loss during the fiscal year. The full-year loss on valuation of investment securities was ¥338 million. - FY2023-Q1WorsenedAnnual report
「Loss on valuation of investment securities 32 260」
The loss on valuation of investment securities for the first quarter was ¥260 million, up from ¥32 million in the same period of the previous year. The risk of declines in the market prices of held shares increased on a quarterly basis. - FY2022-Q3MitigatedAnnual report
「Loss on valuation of investment securities 158 48」
The loss on valuation of investment securities for the cumulative third quarter was ¥48 million, down from ¥158 million in the same period of the previous year. - FY2022-Q2MitigatedAnnual report
「Loss on valuation of investment securities 31 31」
The loss on valuation of investment securities for the cumulative second quarter was ¥31 million, showing a lower level than after the substantial valuation loss recognized in the previous fiscal year. - FY2021WorsenedAnnual report
「Loss on valuation of investment securities: ¥1,452 million」
The loss on valuation of investment securities increased from ¥298 million in the previous fiscal year to ¥1,452 million, indicating that the risk of valuation losses on held shares increased on a full-year basis. - FY2021-Q3MitigatedAnnual report
「Impairment losses on investment securities 257 158」
Impairment losses on investment securities decreased from ¥257 million in the same period of the previous fiscal year to ¥158 million, reducing the scale of the losses year on year. - FY2021-Q2MitigatedAnnual report
「Impairment losses on investment securities 291 31」
Cumulative impairment losses on investment securities for the second quarter were ¥31 million, down from ¥291 million in the same period of the previous fiscal year. - FY2020-Q3MaterialisedAnnual report
「Impairment losses on investment securities 257」
The Company recorded ¥257 million in impairment losses on investment securities for the cumulative third quarter period, and the risk of a decline in the market prices of held shares continued to materialize in actual results. - FY2020-Q2MaterialisedAnnual report
「Impairment losses on investment securities 291」
The Company recorded ¥291 million in impairment losses on investment securities for the cumulative second quarter period, and the impairment risk on held shares materialized in actual results. - FY2018RestatedAnnual report
「Because most of the marketable securities held are listed shares, a decline in share prices could result in impairment losses.」
The risk of a decline in the market prices of held shares was reiterated. - FY2016First statedAnnual report
「The Group holds marketable securities, most of which are listed shares. A decline in the stock market could adversely affect the Group's operating results and financial position.」
Market risk relating to listed shares, including cross-shareholdings.